Chromosomal Instability clinical trials at UCLA

1 in progress, 0 open to eligible people

Sovilnesib in Subjects With Ovarian Cancer
Sorry, in progress, not accepting new patients
This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian cancer (HGSOC).
Los Angeles 5368361, California 5332921 and other locations

Last updated: October 15, 2025